Yanli Wu

No ORCID on file · 3 papers in corpus
other 2026
Preoperative serum HE4 combined with CA125 testing for predicting the risk of suboptimal cytoreduction in advanced epithelial ovarian cancer
Frontiers in oncology ·doi:10.3389/fonc.2026.1886007

OBJECTIVE: To investigate the predictive value of preoperative serum markers centered on human epididymis protein 4 (HE4) combined with carbohydrate antigen 125 (CA125) for the risk of suboptimal cytoreduction in advanced epithelial ovarian…

observational 2023
Cumulative live birth rate in mild versus conventional stimulation in progestin-primed ovarian stimulation protocols for individuals with low prognosis
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1249625

OBJECTIVE: The purpose of this study was to evaluate the cumulative live birth rate (CLBR) of mild stimulation and conventional stimulation for the low-prognosis population undergoing PPOS protocols. METHODS: This was a retrospective cohor…

observational 2022
Effect of serum progesterone levels on hCG trigger day on pregnancy outcomes in GnRH antagonist cycles
Frontiers in endocrinology ·doi:10.3389/fendo.2022.982830

OBJECTIVE: The present study analyzed the effect of hCG trigger day progesterone (P) levels on the live birth rate (LBR) in the gonadotropin-releasing hormone (GnRH) antagonist protocol. MATERIALS AND METHODS: This study was a single-cente…